This approach provides for multidisciplinary and comprehensive solutions for each individual patient. The program treats patients with leukemia, lymphoma, myelodysplasia, breast cancer, ovarian cancer, neuroblastoma, bone and soft tissue sarcomas, brain tumors, bone marrow failure and immunodeficiency disorders. Bone marrow, blood and cord blood cells are used as sources of stem cells according to the needs of the patient. The program is approved by the National Marrow Donor Program , the Southwest Oncology Group and the Children's Cancer Group . The Breast Oncology Program is one of the largest and most comprehensive programs in the Cancer Center.
Patients benefit from expertise in many areas of prevention, diagnosis and treatment.
One of our greatest strengths is in the area of genetics. Women at increased risk are followed closely in the Breast and Ovarian Cancer Risk Evaluation Clinic and engaged in studies to help identify the nature of breast cancer genes. The U-M is a leader in breast preservation and reconstruction. Emphasis also is placed on psychological effects of cancer on women and families, as well as the preventive role of diet. The Breast Oncology Program also has an extensive research effort in Breast Cancer Biology.